Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT vs Mesalamine in Newly Diagnosed UC
NCT03716388Phase 3Unknown
- Sponsor
- Dayanand Medical College & Hospital
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic fecal microbiota in ulcerative colitis (UC), sponsored by Dayanand Medical College & Hospital. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03716388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03716388.